Literature DB >> 7076983

Grain fever syndrome induced by inhalation of airborne grain dust.

G A doPico, D Flaherty, P Bhansali, N Chavaje.   

Abstract

To study the clinical and physiologic manifestations of the grain fever syndrome and the potentially pathogenic role of complement activation, 12 subjects (six grain workers and six healthy non-grain workers) underwent inhalation provocations with airborne grain dust. The clinical response was characterized by facial warmth, headache, malaise, myalgias, feverish sensation, chilliness, throat and tracheal burning sensation, chest tightness, dyspnea, cough, and expectoration. Fever developed in four grain workers and two controls. Leukocytosis, ranging between 11,700 and 24,300 leukocytes/mm3 with left shift, developed in five grain workers and five controls. There was no evidence of complement activation by the classical or alternate pathway. None of the subjects had serum precipitins to grain dust. The pulmonary response was characterized by a decrease in FEV1, FVC, MMF, Vmax50, and Vmax75, with significant rise in pulmonary resistance and consistent change in dynamic compliance but without changes in static compliance or diffusing capacity. Hence, grain dust inhalation induced diffuse airways obstruction without detectable parenchymal reaction. The airways response to high concentrations of grain dust inhalation were unrelated to the presence of immediate skin hypersensitivity. Although we cannot exclude the etiopathogenetic role of an immunologic reaction to grain dust, our data do not support the hypothesis that the grain fever syndrome is a precipitin-mediated allergic pneumonitis. More likely, the manifestations of grain fever probably reflect the host reaction to grain dust bacterial endotoxins and/or nonallergic mediator release by grain or grain dust constituents.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076983     DOI: 10.1016/0091-6749(82)90118-x

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  14 in total

1.  Injurious effects of wool and grain dusts on alveolar epithelial cells and macrophages in vitro.

Authors:  D M Brown; K Donaldson
Journal:  Br J Ind Med       Date:  1991-03

2.  Organic dust toxic syndrome among farmers.

Authors:  A Rask-Andersen
Journal:  Br J Ind Med       Date:  1989-04

Review 3.  Occupational asthma.

Authors:  M Chan-Yeung
Journal:  Clin Rev Allergy       Date:  1986-08

Review 4.  Grain dust and respiratory health.

Authors:  M Chan-Yeung; D Enarson; S Grzybowski
Journal:  CMAJ       Date:  1985-11-15       Impact factor: 8.262

Review 5.  Epidemiology of health and safety risks in agriculture and related industries. Practical applications for rural physicians.

Authors:  J E Zejda; H H McDuffie; J A Dosman
Journal:  West J Med       Date:  1993-01

6.  Diversity of thermophilic and thermotolerant fungi in corn grain.

Authors:  Katrina Sandona; Terri L Billingsley Tobias; Miriam I Hutchinson; Donald O Natvig; Andrea Porras-Alfaro
Journal:  Mycologia       Date:  2019-07-26       Impact factor: 2.696

7.  Health problems in veterinary students after visiting a commercial swine farm.

Authors:  R Jolie; L Bäckström; C Thomas
Journal:  Can J Vet Res       Date:  1998-01       Impact factor: 1.310

8.  Occupational asthma in a hairdressing salon.

Authors:  A D Blainey; S Ollier; D Cundell; R E Smith; R J Davies
Journal:  Thorax       Date:  1986-01       Impact factor: 9.139

9.  COPD in never smokers: results from the population-based burden of obstructive lung disease study.

Authors:  Bernd Lamprecht; Mary Ann McBurnie; William M Vollmer; Gunnar Gudmundsson; Tobias Welte; Ewa Nizankowska-Mogilnicka; Michael Studnicka; Eric Bateman; Josep M Anto; Peter Burney; David M Mannino; Sonia A Buist
Journal:  Chest       Date:  2010-09-30       Impact factor: 9.410

10.  Composition of extracts of airborne grain dusts: lectins and lymphocyte mitogens.

Authors:  S A Olenchock; D M Lewis; J C Mull
Journal:  Environ Health Perspect       Date:  1986-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.